日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data

利用人工智能技术和公开数据,协助实施1型糖尿病筛查。

Teixeira, Pedro F; Battelino, Tadej; Carlsson, Anneli; Gudbjörnsdottir, Soffia; Hannelius, Ulf; von Herrath, Matthias; Knip, Mikael; Korsgren, Olle; Elding Larsson, Helena; Lindqvist, Anton; Ludvigsson, Johnny; Lundgren, Markus; Nowak, Christoph; Pettersson, Paul; Pociot, Flemming; Sundberg, Frida; Åkesson, Karin; Lernmark, Åke; Forsander, Gun

Association between treatment effect on C-peptide preservation and HbA1c in meta-analysis of glutamic acid decarboxylase (GAD)-alum immunotherapy in recent-onset type 1 diabetes

在近期发病的1型糖尿病患者中,谷氨酸脱羧酶(GAD)-明矾免疫疗法的荟萃分析显示,C肽保留与HbA1c的治疗效果之间存在关联。

Nowak, Christoph; Hannelius, Ulf; Ludvigsson, Johnny

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

淋巴内注射 GAD-明矾(Diamyd®)可改善携带 HLA DR3-DQ2 的 1 型糖尿病患者的血糖控制

Nowak, Christoph; Lind, Marcus; Sumnik, Zdenek; Pelikanova, Terezie; Nattero-Chavez, Lía; Lundberg, Elena; Rica, Itxaso; Martínez-Brocca, Maria A; Ruiz de Adana, MariSol; Wahlberg, Jeanette; Hanas, Ragnar; Hernandez, Cristina; Clemente-León, Maria; Gómez-Gila, Ana; Ferrer Lozano, Marta; Sas, Theo; Pruhova, Stepanka; Dietrich, Fabricia; Puente-Marin, Sara; Hannelius, Ulf; Casas, Rosaura; Ludvigsson, Johnny

Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol

一项评估rhGAD65在携带HLA DR3-DQ2单倍型的近期诊断为1型糖尿病的青少年和成人中保护内源性β细胞功能的疗效和安全性的III期、随机、双盲、安慰剂对照、多中心试验:DIAGNODE-3研究方案

Ludvigsson, Johnny; Eriksson, Linnea; Nowak, Christoph; Teixeira, Pedro F; Widman, Martina; Lindqvist, Anton; Casas, Rosaura; Lind, Marcus; Hannelius, Ulf

Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes

GAD-明矾免疫疗法与HLA-DR3-DQ2相关,对新诊断的1型糖尿病患者疗效

Hannelius, Ulf; Beam, Craig A; Ludvigsson, Johnny

The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer

阅读障碍候选基因 DYX1C1 是乳腺癌生存率低的潜在标志

Gustaf Rosin, Ulf Hannelius, Linda Lindström, Per Hall, Jonas Bergh, Johan Hartman, Juha Kere

A genome-wide association scan on estrogen receptor-negative breast cancer

对雌激素受体阴性乳腺癌进行全基因组关联扫描

Li, Jingmei; Humphreys, Keith; Darabi, Hatef; Rosin, Gustaf; Hannelius, Ulf; Heikkinen, Tuomas; Aittomäki, Kristiina; Blomqvist, Carl; Pharoah, Paul Dp; Dunning, Alison M; Ahmed, Shahana; Hooning, Maartje J; Hollestelle, Antoinette; Oldenburg, Rogier A; Alfredsson, Lars; Palotie, Aarno; Peltonen-Palotie, Leena; Irwanto, Astrid; Low, Hui Qi; Teoh, Garrett Hk; Thalamuthu, Anbupalam; Kere, Juha; D'Amato, Mauro; Easton, Douglas F; Nevanlinna, Heli; Liu, Jianjun; Czene, Kamila; Hall, Per